Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Cancer Cell · 2024-09 · 42 (9) · 1614-1629.e5
DOI: 10.1016/j.ccell.2024.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-09. Verfasst von Caitlin A McIntyre und 30 weiteren Autor:innen. Beteiligte Einrichtung: Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Biostatistics and Epi…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Pancreatic Neoplasms, Mutation, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Surgery, Weill Cornell Medicine, New York, NY, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
- Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medicine, New York, NY, USA.
- Department of Surgery, Weill Cornell Medicine, New York, NY, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medici…
- Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- NIBIB NIH HHS
- National Cancer Institute
- American Association for Cancer Research
- National Institutes of Health
- Emerson Collective
Zitieren
APA
McIntyre, C. A., Grimont, A., Park, J., Meng, Y., Sisso, W. J., Seier, K., Jang, G. H., Walch, H., Aveson, V. G., Falvo, D. J., Fall, W. B., Chan, C. W., Wenger, A., Ecker, B. L., Pulvirenti, A., Gelfer, R., Zafra, M. P., Schultz, N., Park, W., …, & Chandwani, R. (2024). Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Cancer Cell, 42(9), 1614-1629.e5. https://doi.org/10.1016/j.ccell.2024.08.002
Vancouver
McIntyre CA, Grimont A, Park J, Meng Y, Sisso WJ, Seier K, et al. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Cancer Cell. 2024;42(9):1614-1629.e5. doi:10.1016/j.ccell.2024.08.002
BibTeX
@article{McIntyre2024,
author = {McIntyre, Caitlin A and Grimont, Adrien and Park, Jiwoon and Meng, Yinuo and Sisso, Whitney J and Seier, Kenneth and Jang, Gun Ho and Walch, Henry and Aveson, Victoria G and Falvo, David J and Fall, William B and Chan, Christopher W and Wenger, Andrew and Ecker, Brett L and Pulvirenti, Alessandra and Gelfer, Rebecca and Zafra, Maria Paz and Schultz, Nikolaus and Park, Wungki and O'Reilly, Eileen M and Houlihan, Shauna L and Alonso, Alicia and Hissong, Erika and Church, George M and Mason, Christopher E and Siolas, Despina and Notta, Faiyaz and Gonen, Mithat and Dow, Lukas E and Jarnagin, William R and Chandwani, Rohit},
title = {Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {9},
pages = {1614--1629.e5},
doi = {10.1016/j.ccell.2024.08.002}
}
EUVIMED